共 50 条
- [43] Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (06): : 643 - 650
- [45] Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2009, 39 (02): : 192 - 195